I am a professional investor as defined in MiFID II.

If none of the previous options apply, please select Rest of World below:

All users

I already invest in Baillie Gifford funds.

Existing investors

Global

I am a professional client or eligible counterparty.

Institutional investor

I invest on my own behalf, am a job seeker, a journalist or want to learn more about Baillie Gifford.

Individual investor

I am a financial advisor or wealth manager.

Intermediaries

Channel Islands

Professional investor

Ireland

I am a due diligence analyst or financial advisor, part of a financial institution or wealth manager.

Financial intermediary

I am a institutional investor as defined by FINRA and the SEC.

Non-professional investor

Wholesale clients

Australia

Austria

Belgium

I am a permitted client as defined in National Instrument 31-103.

Canada

China

Denmark

Finland

France

Germany

Hong Kong

Iceland

Italy

I am a Qualified Client/Qualified Investor.

Qualified investor

Israel

投資運用業

Japan

Luxembourg

Netherlands

Norway

Portugal

Institutional and accredited investors

Singapore

South Africa

I am a qualified professional investor, as defined under the FSCMA.

Qualified professional investor

South Korea

Spain

Sweden

I am a qualified Investor as defined by CISA.

Switzerland

SELECT LOCATION

Investment strategies

Funds

Take your time choosing a fund. You'll want to hold on to it for years.

Insights.

View the latest insights from Baillie Gifford.

You are viewing the site as Institutional in France.

Inclusion.

Actual investors

The Baillie Gifford Prize for Non-Fiction

Person on grand staircase watching the Milky Way.

About us

We relentlessly seek out game-changing companies and other assets that can sustain long-term growth and remain resilient in a changing world. As an investment manager, we aim to deliver strong returns to you while supporting the firms we back on your behalf to succeed.

Life at Baillie Gifford

Working at Baillie Gifford

Frequently asked questions

Careers

Search

Client Login

Contact us

Read the transcript

https://media.bailliegifford.com/mws/onmlqcd3/ep-19-baillie_gifford_julia_angeles_podcast_retail_250321.mp3

Could the messenger RNA vaccines deployed against Covid, help fight cancer and other diseases? After a year of crisis, Julia Angeles, co-manager of Baillie Gifford’s Health Innovation Fund, looks at the positive signs.

Breaking the biotech model

Short Briefings on Long Term Thinking

https://media.bailliegifford.com/mws/u52himvf/baillie-gifford-short-briefings-on-long-term-thinking-episode-19-transcript.pdf

Overview

International viewpoints: the quality derating

December 2025Article|4 minutes

International Alpha: why we do what we do

December 2025Article|8 minutes

Korea’s Value-Up ambition

November 2025Monthly insights|4 minutes

December 2025
Article|4 minutes

December 2025
Article|8 minutes

November 2025
Monthly insights|4 minutes